克拉维酸与CP-45,899：二者与青霉素联合应用的体外活性比较 - Suppr

Suppr

超能文献

Clavulanic acid and CP-45,899: a comparison of their in vitro activity in combination with penicillins.

作者信息

Wise R, Andrews J M, Bedford K A

出版信息

J Antimicrob Chemother. 1980 Mar;6(2):197-206. doi: 10.1093/jac/6.2.197.

DOI:10.1093/jac/6.2.197

PMID:6247316

Abstract

摘要

相似文献

Clavulanic acid and CP-45,899: a comparison of their in vitro activity in combination with penicillins.

J Antimicrob Chemother. 1980 Mar;6(2):197-206. doi: 10.1093/jac/6.2.197.

A study of the in vitro activity of cefoperazone: a comparison with other beta-lactam antibiotics.

Clin Ther. 1980;3(Spec Issue):149-55.

The in vitro activity of mezlocillin when combined with cefoxitin or clavulanic acid.

J Antimicrob Chemother. 1979 May;5(3):301-6. doi: 10.1093/jac/5.3.301.

Clavulanic acid in combination with ticarcillin: an in-vitro comparison with other beta-lactams.

J Antimicrob Chemother. 1984 Feb;13(2):121-8. doi: 10.1093/jac/13.2.121.

In vitro activity of BRL 17421 against Haemophilus influenzae, Neisseria gonorrhoeae, and Branhamella catarrhalis.

Antimicrob Agents Chemother. 1982 Jan;21(1):166-7. doi: 10.1128/AAC.21.1.166.

[Beta-lactamase producers and other bacteria: which ones to take into consideration and when? The concept of beta-lactamase inhibitor].

Presse Med. 1998 Sep;27 Suppl 4:17-8.

Comparative in vitro activity of piperacillin combined with the beta-lactamase inhibitor tazobactam (YTR 830).

Diagn Microbiol Infect Dis. 1989 Nov-Dec;12(6):481-8. doi: 10.1016/0732-8893(89)90082-5.

Synergistic activity of piperacillin in combination with beta-lactamase inhibitors.

Antimicrob Agents Chemother. 1980 Oct;18(4):582-5. doi: 10.1128/AAC.18.4.582.

In-vitro susceptibility of the Bacteroides fragilis group to cefoperazone, ampicillin, ticarcillin and amoxycillin combined with beta-lactamase inhibitors.

J Antimicrob Chemother. 1986 Jan;17(1):125-7. doi: 10.1093/jac/17.1.125.

Comparison of the in vitro activity of Bay k 4999 and piperacillin, two new antipseudomonal broad-spectrum penicillins, with other beta-lactam drugs.

Antimicrob Agents Chemother. 1978 Oct;14(4):549-52. doi: 10.1128/AAC.14.4.549.

引用本文的文献

The development of beta-lactam antibiotics in response to the evolution of beta-lactamases.

Pharm Res. 2001 Oct;18(10):1391-9. doi: 10.1023/a:1012272403776.

Characterization of a PSE-4 mutant with different properties in relation to penicillanic acid sulfones: importance of residues 216 to 218 in class A beta-lactamases.

Antimicrob Agents Chemother. 1998 Sep;42(9):2319-25. doi: 10.1128/AAC.42.9.2319.

Pharmacodynamics of ampicillin-sulbactam in an in vitro infection model against Escherichia coli strains with various levels of resistance.

Antimicrob Agents Chemother. 1998 Feb;42(2):231-5. doi: 10.1128/AAC.42.2.231.

Comparison of concentrations of two doses of clavulanic acid (200 and 400 milligrams) administered with amoxicillin (2,000 milligrams) in tissues of patients undergoing colorectal surgery.

Antimicrob Agents Chemother. 1995 Jan;39(1):94-8. doi: 10.1128/AAC.39.1.94.

Penicillins. A current review of their clinical pharmacology and therapeutic use.

Drugs. 1993 Jun;45(6):866-894. doi: 10.2165/00003495-199345060-00002.

Amoxycillin/clavulanic acid: a review of its antibacterial activity, pharmacokinetics and therapeutic use.

Drugs. 1981 Nov;22(5):337-62. doi: 10.2165/00003495-198122050-00001.

Trapping of nonhydrolyzable cephalosporins by cephalosporinases in Enterobacter cloacae and Pseudomonas aeruginosa as a possible resistance mechanism.

Antimicrob Agents Chemother. 1982 May;21(5):711-7. doi: 10.1128/AAC.21.5.711.

Twenty-one years of beating beta-lactamases.

Br Med J (Clin Res Ed). 1982 Feb 6;284(6313):369-70. doi: 10.1136/bmj.284.6313.369.

Activities of amoxicillin and clavulanic acid combinations against urinary tract infections.

Antimicrob Agents Chemother. 1982 Aug;22(2):346-9. doi: 10.1128/AAC.22.2.346.

In vitro activity of ticarcillin plus clavulanic acid against 632 clinical isolates.

Antimicrob Agents Chemother. 1984 Mar;25(3):392-4. doi: 10.1128/AAC.25.3.392.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验